Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cresco Labs

Explore full profile

Enhancing the lives of Illinois medical cannabis patients and inciting the progressive evolution of the medical cannabis industry

Chicago, United StatesFounded 2014Biotech & Life Sciences
Valuation $814M Market cap · 2026
Revenue $654M Latest reported FY
EBITDA $143M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Cresco Labs

Cresco Labs is a prominent player in the U.S. cannabis industry, known for its comprehensive approach to the market. The company operates as a grower, processor, and retailer of premium cannabis products, serving both recreational users and medical patients. Cresco Labs is publicly traded under the ticker symbols CSE: CL and OTCQX: CRLBF, which means its shares are available for public investment.

Read full description

Cresco Labs targets a broad spectrum of consumers, from those who are well-versed in cannabis to newcomers. The company’s portfolio includes a variety of trusted brands designed to meet different consumer needs, ensuring a consistent and high-quality experience. This approach allows Cresco to cater to diverse lifestyles and preferences, giving consumers the control and reliability they seek.

Operating in eleven states, Cresco Labs focuses on markets with high demand and stringent regulations, which act as barriers to entry for competitors. This strategic focus allows the company to capitalize on significant growth opportunities while maintaining a competitive edge. Cresco Labs emphasizes shared value, meaning that its success translates into benefits for its stakeholders, including local communities and the broader industry.

The company is committed to responsible industry practices, exceeding regulatory requirements to set higher standards. This includes collaborating with local governments to establish appropriate regulations, designing eco-friendly packaging, and supporting community empowerment and education initiatives. Cresco Labs aims to build an industry that is both reputable and enjoyable for all participants.

Cresco Labs generates revenue through the cultivation, manufacturing, and retailing of cannabis products. Its state-of-the-art facilities and expert team ensure the delivery of top-tier products, whether for recreational enjoyment or medical relief. By maintaining high standards and focusing on quality, Cresco Labs continues to grow its market presence and consumer trust.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Chicago, United States
Listing
IPO 2018
Employees
1,289
Open positions
39
Dealroom signal
68.1/100
Industry
Health, Food
Sub-industry
BioTechnology, Innovative Food
Sector
Biotech & Life Sciences, Wholesale, Retail, Biotechnology, Cannabis, Novel Farming, Biotech and Pharma, Hard Tech, Quasi tech
Business model
Manufacturing
Client focus
b2b
Investment activity
7 companies, latest Mar 2022
Capital deployed
Preferred round
ACQUISITION

Latest news

Press, funding announcements and product moves mentioning Cresco Labs.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Jun 2026 $50M Needham Bank
POST IPO DEBTDebt Aug 2025 $325M Undisclosed
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMargin
2026 $654M -0.2% $143M 21.9%
2025 $656M -9.5% $145M 22.1%
2024 $724M -6% $116M 16%
2023 $771M -8.5% $135M 17.6%
2022 $843M +2.6% $123M 14.7%
2021 $822M +72.5% $133M 16.2%
2020 $476M $98M 20.6%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Cresco Labs website traffic

Latest recorded traffic for Cresco Labs is 29K monthly website visits, down 37% over the last three months. Cresco Labs's team grew 2.1% over the past year.

Latest monthly visits29K 3-month web change-37% 1-year team growth+2.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Erecruit

Series B and later2 investors entered at this stage

  • BAM Elevate
  • Needham Bank
Team profiled 34 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States98.6%
🇨🇦 Canada0.5%
🇦🇪 United Arab Emirates0.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cresco Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cresco Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.